Iwazaki R, Maehiro K, Iijima K, Ota K, Ono Y, Sato K, Okura R, Miwa H, Sato N, Mizobuchi N, Urabe M, Wada R
Department of Gastroenterology, Juntendo University School of Medicine, Japan.
Gan To Kagaku Ryoho. 1996 Feb;23(3):355-9.
We here reported a case of advanced gastric cancer remarkably responding to preoperative short-term UFT-E chemotherapy. UFT-E was orally administered preoperatively for about a month to the patient with type 2 advanced gastric cancer. After the chemotherapy the cancer was found to be remarkably decreased in size and denatured. The amount of residual cancer cells was limited by histopathological examination following the operation and diagnosed as Grade 3 based on the criteria of histological evaluation of chemotherapy for cancer. We continued to administer UFT-E postoperatively and the patient is still alive without symptoms.
我们在此报告一例晚期胃癌患者对术前短期UFT-E化疗有显著反应。对于一名2型晚期胃癌患者，术前口服UFT-E约一个月。化疗后发现肿瘤大小显著减小且发生变性。术后组织病理学检查显示残留癌细胞数量有限，根据癌症化疗组织学评估标准诊断为3级。我们术后继续给予UFT-E治疗，该患者目前仍然存活且无症状。
